Category: Covid-19

Page 476«..1020..475476477478..490500..»

Atea’s antiviral pill fails to clear Covid-19, forcing a re-think – STAT – STAT

October 19, 2021

Atea Pharmaceuticals said Tuesday that its antiviral pill for Covid-19 failed to combat the virus in a mid-stage trial, leading the company to delay its pivotal study by a year.

The disappointing news follows a far more hopeful October update from Merck, whose similar antiviral reduced the chances that patients newly diagnosed with Covid-19 would be hospitalized by about 50% in a Phase 3 study.

There is a desperate need for treatments for early Covid that can be taken as pills. Current treatments, such as remdesivir and monoclonal antibodies, are generally given intravenously or as injections, and are difficult to distribute to large numbers of people. The hope is that pills to treat Covid could be given widely in order to prevent infected people from progressing to severe disease, hospitalization, or death.

advertisement

Atea, partnered with global drug maker Roche, said its drug, AT-527, failed to beat placebo at reducing the amount of measurable virus in patients with mild or moderate Covid-19, missing the primary endpoint of a 100-patient trial.

As a result, Atea and Roche are rethinking their Phase 3 trial. That study, designed to enroll up to 1,400 patients, has a primary endpoint of reducing the time it takes patients to recover from Covid-19 and secondary goals including preventing hospitalization. In light of the Phase 2 results, Atea and Roche are now considering whether to change the primary endpoint and target population. Data from that study, once expected this year, are now slated for the second half of 2022, Atea said.

advertisement

AT-527 works similarly to Mercks drug, molnupiravir, and was widely expected to succeed in clinical development. The problem might have been trial design. While Merck deliberately excluded patients who had been vaccinated for Covid-19, Atea did not, which might have skewed the results, according to the company. Merck also recruited only patients who had at least one risk factor for severe Covid-19, such as obesity or heart disease, while Atea required only a positive test and mild symptoms.

In a subgroup of patients at high risk for severe Covid-19, AT-527 outperformed placebo at reducing virus levels over seven days, Atea said, which could inform the companys changes to its Phase 3 trial.

Based on what we know now, this actually is not surprising, as other direct-acting antivirals, including molnupiravir, have shown similar outcomes in the mild-to-moderate outpatient population, Atea CEO Jean-Pierre Sommadossi said on a conference call with analysts Tuesday. What is reassuring is that viral reduction was observed in high-risk patients with underlying health conditions.

The news is a bitter disappointment for Atea, which has spent the past 18 months touting the potential of AT-527, developed as a treatment for hepatitis C, to change the course of the Covid-19 pandemic. The company, which commanded a market value of about $3.4 billion as of Monday, fell 70% in premarket trading on Tuesday.

Merck, partnered with Ridgeback Biotherapeutics, is seeking an emergency use authorization for its Covid-19 antiviral and will make its case to a panel of Food and Drug Administration advisers on Nov. 30. Results for another potential oral Covid-19 treatment, from Pfizer, are expected by the end of the year.

More:

Atea's antiviral pill fails to clear Covid-19, forcing a re-think - STAT - STAT

Governor Hochul Announces New COVID-19 Data Hub Website to Expand Public Access, Centralize Information and Improve the User Experience – ny.gov

October 19, 2021

The new website marks the creation of a single landing page for COVID-19 dashboards that is easy to access, rather than having to navigate different dashboards on different platforms. The new data homepage links to 16 key data pages organized into five major categories. In addition, the Department of Health retooled several dashboards that were created early in the pandemic to provide information in a manner that is easier to understand and more relevant to current needs.

SUMMARY OF DASHBOARD UPDATE

On the new COVID-19 Testing Dashboard:

The COVID-19 Early Warning Monitoring Dashboard hasbeen removedas it was built to support regional reopeningmetrics that are no longer relevant. Cases per 100k is available on the COVID-19 Testing Dashboard, and detailed hospitalizationinformation isnow available on Health Data NY.

SUMMARY OF DATASET UPDATES

In addition to the dashboards, additional datasets are now available on Health Data NY, a public database that allows users to access health information in multiple downloadable formats such as Excel. Health Data NY now includes additional self-reported data from the COVID-19 School Report Card, nursing home and adult care facility fatality data, and hospital admissions by gender and zip code, as well as hospital capacity and staff vaccination numbers.

Full list of additions to Health Data NY:

Link:

Governor Hochul Announces New COVID-19 Data Hub Website to Expand Public Access, Centralize Information and Improve the User Experience - ny.gov

Nearly every person in Iran seems to have had covid-19 at least once – New Scientist

October 19, 2021

By Catherine Shaffer

A student waiting to receive a covid-19 vaccine in Irans capital Tehran

AFP via Getty Images

Nearly everyone in Iran has beeninfected by the coronavirus at some point during the covid-19 pandemic, and some have caught the virus more than once, but the country still hasnt achieved herd immunity. Instead, Iran is seeing apunishing new wave of deaths driven by the delta variant.

Iran was one of the first countries after China to be hit by the pandemic, and it had a slow start to its vaccine roll-out. By July

Visit link:

Nearly every person in Iran seems to have had covid-19 at least once - New Scientist

Convicted murderer Robert Durst hospitalized with COVID-19 – ABC News

October 19, 2021

Durst appeared in court two days ago for his sentencing.

October 16, 2021, 10:01 PM

5 min read

Robert Durst has been diagnosed with COVID-19, his attorney confirmed Saturday, two days after the real estate heir was sentenced to life in prison on a first-degree murder conviction. He is currently in the hospital, county records show.

Durst, 78, was sentenced Thursday in Los Angeles Superior Court to life in prison without the possibility of parole for the 2000 killing of Susan Berman, his close confidant. The wheelchair-bound Durst appeared in the courtroom for his sentencing, looking frail and wearing a face mask.

Robert Durst is sentenced to life in prison without the possibility of parole for killing his best friend Susan Berman at the Airport Courthouse, Oct. 14, 2021, in Los Angeles.

His attorney, Dick DeGuerin, did not share any additional details on Durst's condition with ABC News. However, the Los Angeles County Sheriff's Department's inmate records show he was admitted late Friday to the LAC + USC Medical Center in Los Angeles.

During his testimony in August, Durst detailed a litany of health ailments, including esophageal and bladder cancers, chronic kidney disease and chronic obstructive pulmonary disease, or COPD. He spoke with a raspy, weak voice, impacted by surgery for his esophageal cancer and COPD.

The high-profile trial has been plagued by a series of delays due to the pandemic. After two days of testimony, the trial was delayed for 14 months after the coronavirus shuttered courts, with testimony resuming in May.

In August, testimony was briefly paused again after a courtroom observer tested positive for COVID-19. There was another holdup in June, when Durst was hospitalized for an unspecified health issue.

Robert Durst seated with attorney Dick DeGuerin, was sentenced to life without the possibility of parole, Oct. 14, 2021, in Los Angeles.

Durst did not appear in the courtroom when the verdict was announced in September because he was in quarantine after being exposed to COVID-19 by one of his sheriff drivers. Jurors found him guilty after deliberating for about seven hours over three days.

The New York real estate scion was accused of killing his best friend, Berman, who was shot in the back of the head in her Los Angeles home in 2000. Prosecutors alleged Durst killed Berman to prevent her from telling police she helped him cover up the unsolved murder of his wife, Kathleen Durst, in 1982. Durst has never been charged in his wife's disappearance.

Durst pleaded not guilty in 2018 to the murder charge for Berman's death. His attorneys have unsuccessfully sought a mistrial, arguing the lengthy delay impeded his chances of a fair trial.

Durst was also charged in the 2001 killing of a neighbor in Galveston, Texas. He claimed self-defense and was acquitted.

ABC News' Cassidy Gard contributed to this report.

Originally posted here:

Convicted murderer Robert Durst hospitalized with COVID-19 - ABC News

Biden Admin to Lift COVID-19 Travel Restrictions for Vaccinated – The National Law Review

October 19, 2021

Susan is an immigration lawyer with over fifteen years of experience assisting individuals, families, and employers in connection with assessing available U.S. immigration options.

Her practice includes preparing and filing individual, family-based, and employment-based petitions, immigrant and nonimmigrant visa applications, and waivers of inadmissibility. She assists with complex consular processing issues, complicated citizenship and naturalization issues, petitions for humanitarian relief, and removal defense. She advises employers regarding worksite compliance, conducting...

Excerpt from:

Biden Admin to Lift COVID-19 Travel Restrictions for Vaccinated - The National Law Review

Lawyer: Robert Durst is in the hospital with COVID-19 – NPR

October 17, 2021

Robert Durst, seated with attorney Dick DeGuerin, was sentenced to life in prison on Thursday without chance of parole for the murder of Susan Berman more than two decades ago. Myung J. Chun/Los Angeles Times via AP hide caption

Robert Durst, seated with attorney Dick DeGuerin, was sentenced to life in prison on Thursday without chance of parole for the murder of Susan Berman more than two decades ago.

LOS ANGELES New York real estate heir Robert Durst, who days ago was sentenced in a two-decade-old murder case, has been hospitalized after contracting COVID-19, his lawyer said Saturday.

Defense Attorney Dick DeGuerin said he was notified that Durst was admitted after testing positive for the coronavirus. DeGuerin said he didn't know Durst's condition and was trying to find out more details.

The Los Angeles Superior Court said in a statement Saturday that the court was notified someone present for the sentencing hearing Thursday had tested positive for COVID-19.

"As a result, the Court will follow CDC and LA County Department of Public Health guidelines for assessing close contacts of the infected individual," the statement read.

No additional COVID-19 cases have been reported.

Durst, 78, was sentenced Thursday to life in prison without a chance of parole for the murder of his best friend more than two decades ago. Durst, who has numerous medical issues, sat in a wheelchair with a catatonic stare during much of the sentencing hearing.

"He was very, very sick in the courtroom," DeGuerin said Saturday.

He was convicted in Los Angeles Superior Court last month of first-degree murder for shooting Susan Berman point-blank in the back of the head at her home in December 2000.

The killing had been a mystery that haunted family and friends for 15 years before Durst was arrested in 2015 following his unwise decision to participate in a documentary that unearthed new evidence and caught him in a stunning confession.

DeGuerin said Thursday that Durst will appeal.

See the original post here:

Lawyer: Robert Durst is in the hospital with COVID-19 - NPR

State records 4,485 new COVID-19 infections; 83 in Valley – Sunbury Daily Item

October 17, 2021

The Daily Item

Pennsylvania Health Department officials recorded zero COVID-19-related deaths for the second consecutive Saturday, but added 4,485 new infections, pushing the states October total to 76,669.

The deaths report ended a string of four consecutive days with 80 or more. Last week, the state reported no new deaths on Saturday, Sunday or Monday, but despite that the last seven-day period still included almost 100 more deaths 511 compared to 419 than the previous week, according to Health Department data.

There have been 1,018 COVID-19-related deaths in the first 16 days of October. There were 1,165 in all of September and 670 in all of October 2020.

The new infection total ends a streak of three consecutive days with 5,000 or more infections. There were 83 new cases in the Valley, including 52 in Northumberland County, the fourth consecutive day with 50 or more in the county. There were also 13 more in Montour County, the fourth consecutive day with 13 or more. Union County added 12 cases and Snyder added six.

All 67 counties in Pennsylvania are reporting high levels of community transmission of COVID, according to the Centers for Disease Control and Prevention, which means they are all seeing at least 100 new cases per 100,000 residents over the previous seven days. Nationwide, 87.7 percent of counties have high transmission rates, down .8 percent from Friday.

According to state data, more than 13.2 million COVID vaccine doses have been administered in Pennsylvania and 70.1 percent of residents 18 and older are fully vaccinated, including 88,346 in the Valley. The state did not update its vaccination statistics on Saturday.

Bucknell University had a dozen active cases on campus, including seven staffers and five students. Susquehanna University reported nine active cases, six staffers and three students. Both schools updated their data on Friday.

As of noon Saturday, there were 2,978 patients in Pennsylvania hospitals with COVID-19 symptoms, up 32, ending a streak of two consecutive days of decreases.

Of those hospitalized, 682 were being treated in intensive care units (ICUs), down five, and 389 were being treated on ventilators, down five.

According to data provided by the state, there were 95 patients undergoing treatment in Valley medical facilities for COVID-19 on Saturday. There were 19 patients in intensive care units at Geisinger in Danville up one from Friday eight at Evangelical Community Hospital near Lewisburg up two for the second day in a row and none at Geisinger-Shamokin.

Geisingers Danville location was also treating five on ventilators, three fewer than the day before. Evangelical was treating one patient on a ventilator.

At Geisingers main campus in Danville, there were 51 COVID-19 positive patients, two fewer than reported on Friday. There were 36 patients at Evangelical and eight at Geisinger-Shamokin.

There were eight active staff cases at the State Correctional Institution (SCI) in Coal Township as of Saturday. There were 98 staff cases statewide, down six. There were 78 active inmate cases statewide an increase of 40 but none at Coal Township.

There were seven active cases at federal prisons in Union County, including three inmate cases at the low-security unit in Allenwood and one staff case at the medium-security prison, according to the Federal Bureau of Prisons. At the U.S. Penitentiary (USP) in Allenwood, there were three cases, two staffers and one inmate. There were no cases at USP Lewisburg.

The state Department of Human Services (DHS) was still reporting 13 active cases among staffers at the Selinsgrove Center on Saturday. There were less than five cases among persons receiving services. The DHS does not specify numbers when they are fewer than five to avoid identifying patients.

There were six staff cases and less than five client cases at Danville State Hospital for the fifth consecutive day on Saturday.

There were less than five youth cases at the North Central Secure Treatment Unit (NCSTU) for girls on Saturday. There were no staff cases in the unit and no cases in the NCSTU boys unit.

Continue reading here:

State records 4,485 new COVID-19 infections; 83 in Valley - Sunbury Daily Item

A dad who traveled 1,200 miles for Covid-19 care is finally going home. Here’s what he wants you to know – CNN

October 17, 2021

But Robby Walker is alive -- a feat some doctors didn't expect two months ago. And while the 52-year-old struggles to speak long sentences, he's now using his voice to try to prevent others from suffering the way he did.

Now, after three weeks on ECMO and a month learning how to walk again, Robby returned to Florida this week -- with a new mission.

A different life after Covid-19

Before Robby fell ill in July, he was a strong and sturdy construction business owner who worked out at the gym and ran 5 miles every day.

"Fifty-two years, I've done pretty much whatever I wanted," Robby told CNN. "Now, I'm very limited."

Scarred lungs and reduced lung capacity means he can only speak in short, choppy sentences before having to catch his breath. He also lost more than 50 pounds while hospitalized as his muscles eroded.

Even brushing his teeth is now a struggle.

"Sitting in a chair, it's probably a 5- or 6-minute ordeal," Robby said.

"If I stand, then I have to take a break between. So it's a little longer," he said.

"It takes a lot more energy to hold yourself up. I can go from sitting in a chair to standing, and my heart rate will jump 20, 30 beats a minute."

After his ECMO treatment at Connecticut's Saint Francis Hospital, Robby spent a month in physical therapy at Gaylord Speciality Healthcare about 30 miles away.

He relearned how to walk and practiced basic self-care with the help of an assistant. But he still needs a walker to move around, and small tasks can be draining -- even after taking a break.

"Once your heart rate comes down and your breathing gets straight, you're still just exhausted," he said. "Physically. It just takes a lot of energy to do."

But the fact he's even alive is worth celebrating.

'They told me he was dying'

Robby called his wife on July 25 from his hospital bed in Florida and told her he had made a gut-wrenching decision.

"He had signed the papers to be intubated," Susan said.

Some Covid-19 patients who get put on ventilators don't survive the disease. Their final calls to their families before intubation are their last.

"He cried and just told me how regretful he was of not getting the shot," Susan said. "And he begged me to go get vaccinated."

She did. But it was too late to protect her husband, whose condition kept deteriorating.

"They told me he was dying," Susan said. And the ECMO treatment Robby needed wasn't available.

Susan told her story to CNN in August. Hours later, a doctor 1,200 miles away was checking his Facebook feed and saw a CNN post with a video clip of Susan's interview.

"I just clicked on it and watched it and ... it was pretty compelling," said Dr. Robert Gallagher, chief of cardiothoracic surgery at Trinity Health of New England.

Cardiothoracic surgeons operate on diseases in the chest, including in the heart and lungs. By the time Covid-19 patients reach Gallagher, they're usually in dire condition -- and often in need of ECMO.

"I said, 'OK, how are we going to find this family?'" Angela Sakal, the chief perfusionist at Saint Francis Hospital in Connecticut, told CNN.

She contacted a friend in Florida who's savvy on social media. "And within a couple of hours, she had Susan's phone number," Sakal said.

Within two days, Susan hired a medical evacuation team to fly Robby from Florida to Connecticut -- intubated, sedated and near death.

When Sakal first saw Robby, she wasn't sure he would survive.

"I can't guarantee you an outcome," she recalled telling Susan. "I don't know what the future is going to be. But I can promise you that we're going to do the best that we can for him."

ECMO is sometimes used as a last resort for critically ill Covid-19 patients with failing lungs. It removes blood from the body, eliminates carbon dioxide and adds oxygen to the blood, then pumps the blood back into the body so the lungs might have a chance to recover.

Gallagher inserted the ECMO tubes in Robby's neck. And over the next 22 days, Sakal oversaw Robby's ECMO treatment.

Younger Covid-19 patients are needing ECMO

Robby isn't the only previously healthy Covid-19 patient Sakal has seen needing ECMO.

With the rise of the Delta variant, Sakal said some ECMO patients have been in their 20s.

"What we're finding is our Covid patients -- even the young ones -- are single organ failure (and) previously healthy," Sakal said. "And the Covid is just destroying their lungs."

Not everyone who goes on ECMO survives. But after three weeks of getting his blood extracted and returned, Robby's lungs had recovered enough to support him again.

He was discharged from Saint Francis in mid-September and started a month of inpatient rehabilitation at Gaylord Specialty Healthcare.

"My lungs have gotten a little bit better, (but) my heart rate still races a little bit," Robby said this week.

"I can walk by myself -- somebody's there just kind of making sure I'm staying straight. But I use a roller/walker, and I'm able to walk a decent distance," he said.

"I mean, I'm not going to the mall or going shopping. But I'm able to walk some now. So it's been a big improvement."

After a month of difficult work relearning basic skills, Robby was released from rehab Wednesday. Most of his ECMO team from Saint Francis Hospital traveled to Gaylord to see him off to Florida.

Sakal was there. She fought back tears as she visited her former patient.

"I remember when he first got here," she said Wednesday. "And I watched him today, standing up and talking and walking. It was amazing. It was just awesome."

A new life filled with uncertainty and lessons learned

Robby's two brothers rented an RV and drove up to Connecticut to bring him and Susan home. The drive would take more than 24 hours.

As he traveled back to Florida to restart his life, Robby said the first thing he wanted was his wife's homemade chicken pot pie.

But many other aspects of his former life will be different.

It's not clear when Robby might be able to go to work again, as he still needs months more of rehabilitation.

And Robby doesn't know whether he'll be able to return to all the activities he loved.

"My goal is to get hopefully 80% or 90% to where I was," he said. But "they just don't know enough about this to give any kind of definitive answers."

For now, he won't be able to go fishing or work out at the gym every day.

"I don't have a lot of strength," he said, joking about fishing: "I wouldn't want anything to pull me over the reel."

But what he lacks in physical ability, he's gained in new wisdom -- especially when it comes to Covid-19 and vaccines.

Robby said the reason he and Susan didn't get vaccinated earlier was due to "a lack of education on our part."

With countless rumors and claims spread on social media, "you don't know what to believe anymore," he said. "A lot of that was ignorance on our part, for not doing more research."

"We thought that the vaccine was something that was created in a year or two. So we felt like there wasn't enough information," he said.

He also wrongly assumed that he wouldn't get severely sick.

"I just thought it would be like a flu. I thought that it was something that affected people with underlying conditions. I had none," Robby said.

"But for whatever reason, it affected me differently. And if I had to do it over again, I would have gotten my vaccination when it was available to me."

After he left the hospital, Robby received his first dose of the Moderna vaccine. He had some side effects for a day, he said, but they weren't nearly as bad as his Covid-19 symptoms.

"There was a little fever ... my first few days of Covid, I had a bigger fever than that," Robby said.

"I just had no energy. I did run a fever for probably a day, day and a half. But nothing horrible compared to everything else I've gone through."

Originally posted here:

A dad who traveled 1,200 miles for Covid-19 care is finally going home. Here's what he wants you to know - CNN

More Covid-19 boosters are on the horizon. But not everyone will need one, experts say – CNN

October 17, 2021

The group voted Friday to authorize a booster shot of Johnson & Johnson's vaccine for Americans 18 and older at least two months after they get their first shots. Johnson & Johnson said studies showed boosting at two or six months can bring effectiveness up to 94%.

If the FDA follows its advisers' recommendations, more than 90% of people vaccinated with the Johnson & Johnson shot -- nearly 14 million people -- will be eligible for the booster right away.

Anyone who got the single-shot Johnson & Johnson vaccine "can benefit from a second dose" of it," Dr. Paul Offit, a member of the FDA Vaccines and Related Biological Products Advisory Committee, told CNN's Jake Tapper on Friday.

Yet some experts are noting that while antibodies may wane over time, the initial two-dose regimen for both the Pfizer and Moderna vaccines is still holding up against severe Covid-19 infection.

"We have to define what's the goal of this vaccine. If the goal of this vaccine is protection against serious illness, meaning the kind of illness that causes you to seek medical attention or go to the hospital or the ICU, the current vaccines, as two-dose vaccines, are doing exactly that," he said. "So, you don't really need a booster dose, at least as far as those data are concerned."

Offit said that although he voted to recommend half-dose booster shots for some people six months after their first two doses of Moderna's vaccine, he doesn't think everyone needs one.

"I do worry about the sort of 18- to 29-year-old because that's the group that has a higher risk of myocarditis -- that's inflammation of the heart muscle," he said. "So, without sort of clear benefit that that third dose is necessary, I think we've created this kind of 'third dose fever' in this country because of the way this has played out."

Dr. Michael Kurilla, director of the Division of Clinical Innovation at the National Center for Advancing Translational Sciences at the National Institutes of Health, agreed.

"I don't see the need for a let-it-rip campaign for boosters," Kurilla said.

The number of people getting booster doses is currently outpacing the number of people getting their first doses of vaccine, according to CDC data. More than a million doses were reported administered Wednesday, but just an average of around 230,000 people are starting the vaccination process each day.

"We're down to 66 million, still unacceptably high number of unvaccinated people," he said Thursday. "Now's not the time to let up."

The FDA will consider the committee's recommendations, and if an EUA is approved, then the CDC will confer about which groups would be eligible.

Vaccine mandates move forward

As the discussion on boosters continues, experts consistently point to the greater need to inoculate those unvaccinated to get ahead of the pandemic. And while many Covid-19 vaccine mandate campaigns from the public and private sectors have met with success, some agencies are finding pushback from a vocal subset.

Many state employees in Washington are four days away from a deadline for being fully vaccinated against Covid-19, and officials will not extend that deadline further.

"If people do make the choice to leave public service, we will replace them," Gov. Jay Inslee said Thursday.

More than 90% of state employees have provided proof of vaccination, Inslee said, and about two percent more have been given special accommodations that will allow them to remain unvaccinated due to medical conditions or religious convictions.

"We know that there are staff members that will refuse to be vaccinated," Joan Hall, president of Nevada Rural Hospital Partners, said in a briefing Thursday. Vaccination rates for employees at their hospitals range from 60% to 90%, Hall said.

Meanwhile, a Massachusetts district judge denied a request from the state's correction officers union to issue a preliminary injunction to block a statewide vaccine mandate that requires all executive department employees to be vaccinated by October 17, according to court documents.

The Massachusetts Correction Officers Federated Union and several other individuals alleged the governor and corrections department commissioner violated the Contracts Clause of the US Constitution and their 14th Amendment Rights by enforcing the mandate. An attorney for the union, McDonald Lamond Canzoneri, said about 40% of members of the union were unvaccinated as of Friday, according to court documents.

But experts have consistently pointed out that areas with higher rates of vaccination are faring better with Covid-19 hospitalizations.

The Covid-19 hospitalization rate in the city's public health system has reached its lowest point since the beginning of the pandemic, according to Dr. Mitchell Katz, CEO of NYC Health + Hospitals.

Antiviral pill application will be reviewed

Vaccines have been proven to be the most effective means of Covid-19 protection, yet the measure is a preventative one. An antiviral pill that may help those newly infected is now slated for review next month.

If authorization is eventually granted, the drug -- which comes in capsule form -- would be the first oral antiviral treatment to fight Covid-19.

"Through Day 29, no deaths were reported in patients who received molnupiravir, as compared to 8 deaths in patients who received placebo," the statement said.

The FDA noted it doesn't always convene an advisory committee meeting to discuss a potential EUA, but it can when the committee discussion would help inform the agency's decision-making.

"We believe that, in this instance, a public discussion of these data with the agency's advisory committee will help ensure clear understanding of the scientific data and information that the FDA is evaluating to make a decision about whether to authorize this treatment for emergency use," Dr. Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research, said in a statement.

CNN's Virginia Langmaid, Jen Christensen, Maggie Fox, Lauren Mascarenhas, Andy Rose, Peter Nickeas, Laura Ly and Casey Riddle contributed to this report.

Go here to read the rest:

More Covid-19 boosters are on the horizon. But not everyone will need one, experts say - CNN

Cam Newton reportedly receives COVID-19 vaccine as he looks to sign with NFL team – Sporting News

October 17, 2021

Cam Newton appears to be doing all he can to make himself signable for an NFL team.

Newton has received the COVID-19 vaccine as teams have remained in contact with the former Patriots quarterback,NFL Network's Mike Garafolo reported Saturday.

Garafolo also reported during an appearance on "Good Morning Football Weekend" that no Newton signing is imminent but teams have been in touch with him through the first six weeks of the season.

MORE:Newton joins shirtless Bruce Pearl in student section ahead of Auburn vs. Georgia

"A lot of folks are saying, 'Did Newton's vaccination status factor into whether New England kept him, and whether he would latch on elsewhere?' That's no longer a storyline here," Garafolo said."Again, teams have been informed . . . that Cam Newton is now vaccinated. So even if he came in, he wouldn't have to wait five days before he works out or joins your roster."

Newton had to spend five days away from the Patriots during the preseason after what was termed amisunderstanding of the team's COVID-19 policies.

MORE:Cam Newton opens up on why he was cut by the Patriots

Less than a week later, the Patriots cut Newton and named rookie Mac Jones the team's starting quarterback. Patriots coach Bill Belichick said Newton's vaccination status was not why he was cut, but that didn't stop speculation from running rampant.

Jones has led the Patriots to a 2-3 start. He has completed 71.1 percent of his passes, with 1,243 yards, five touchdowns and five interceptions.

MORE:NFL vaccine rules, explained

Newton's vaccination status will make it easier for him to join a team. The NFL's COVID-19 rules allow vaccinated players to avoid quarantines even in the case of a close contact with infected individuals. In the event of a breakthrough positive, the vaccinated player has to wait only until he has received two negative tests 24 hours apart. Then the player will face weekly testsor be tested only as directed by medical staff.

Unvaccinated players who test positive have to be isolated for at least 10 days and cannot return until they are asymptomatic. Unvaccinated players also are subject to five-day quarantines if they are in close contact with infected individuals.

Additionally, unvaccinated players have to be tested each day for COVID-19, wear masks at all times in the facility, cannot gather in groups larger than three people and are subject to fines if they break NFL coronavirus protocols. Free agents have to test negative for five straight days before entering a team facility.

Read the original:

Cam Newton reportedly receives COVID-19 vaccine as he looks to sign with NFL team - Sporting News

Page 476«..1020..475476477478..490500..»